Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Sodium Oxybate: Difference between revisions

From Pharmacopedia
[unchecked revision][unchecked revision]
Sweep: "indications" -> "problems" sitewide terminology update (preserves MedTemplate param name)
Em-dash sweep: replace em-dash with comma per project rule; PendellsCorner verbatim quotes preserved.
 
Line 15: Line 15:
| bioavailability = ~25% (high first-pass)
| bioavailability = ~25% (high first-pass)
| pregnancy = Category C
| pregnancy = Category C
| legal = Schedule III; REMS-restricted (Schedule I if outside the pharmaceutical channel same molecule as illicit GHB)
| legal = Schedule III; REMS-restricted (Schedule I if outside the pharmaceutical channel, same molecule as illicit GHB)
| mechanism = Agonist at the metabotropic GABAB receptor and the endogenous γ-hydroxybutyrate (GHB) receptor. Produces deep sleep with increased slow-wave architecture, suppression of REM intrusion, and cataplexy reduction.
| mechanism = Agonist at the metabotropic GABAB receptor and the endogenous γ-hydroxybutyrate (GHB) receptor. Produces deep sleep with increased slow-wave architecture, suppression of REM intrusion, and cataplexy reduction.
| intro = Sodium oxybate is the sodium salt of [[GHB]], formulated as a high-purity oral solution dosed in grams. It is among the most effective treatments for cataplexy and excessive daytime sleepiness in narcolepsy. Because its half-life is so short, it must be taken in two doses separated by 2.5–4 h during the night. Pharmacy-distributed only through a REMS program; the same compound outside that channel is Schedule I.
| intro = Sodium oxybate is the sodium salt of [[GHB]], formulated as a high-purity oral solution dosed in grams. It is among the most effective treatments for cataplexy and excessive daytime sleepiness in narcolepsy. Because its half-life is so short, it must be taken in two doses separated by 2.5–4 h during the night. Pharmacy-distributed only through a REMS program; the same compound outside that channel is Schedule I.
Line 29: Line 29:
| pregnancy_details =
| pregnancy_details =
| monitoring = Sleep quality; daytime sedation; respiratory status (caution in sleep apnea or with concurrent CNS depressants).
| monitoring = Sleep quality; daytime sedation; respiratory status (caution in sleep apnea or with concurrent CNS depressants).
| counseling = '''Take only in bed and only when ready to sleep''' onset is rapid. Severe sedative interactions with alcohol or other CNS depressants. Significant sodium load (~1100 mg per 4.5 g/night) consider Xywav for sodium-restricted patients.
| counseling = '''Take only in bed and only when ready to sleep''', onset is rapid. Severe sedative interactions with alcohol or other CNS depressants. Significant sodium load (~1100 mg per 4.5 g/night), consider Xywav for sodium-restricted patients.
| anecdotes =
| anecdotes =
| seealso = [[GHB]], [[GBL]], [[Modafinil]], [[Pitolisant]]
| seealso = [[GHB]], [[GBL]], [[Modafinil]], [[Pitolisant]]